Log In
BCIQ
Print this Print this
 

pseudoephedrine/levocetirizine (HCP0703)

  Manage Alerts
Collapse Summary General Information
Company Hanmi Pharmaceutical Co. Ltd.
DescriptionFixed dose combination of pseudoephedrine and levocetirizine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase III
Standard IndicationRhinitis
Indication DetailsTreat vasomotor rhinitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today